FindMyKOL
Clinical trialNCT00257465CompletedPhase 1/PHASE2Interventional

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

SponsorAVAX TechnologiesEnrollment82Melanoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether a vaccine composed of patients' own melanoma cells treated with the chemical, dinitrophenyl (DNP)(called a hapten), is safe and stimulates an immune response to patients' own cancer cells.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arizona Cancer Center

    Tucson, Arizona, United States

  • Pacific Oncology and Hematology Associates

    San Diego, California, United States

  • University of Illinois School of Medicine

    Chicago, Illinois, United States

  • University of Louisville

    Louisville, Kentucky, United States

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Autologous, DNP-Modified Melanoma VaccineAutologous, DNP-Modified Vaccine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2005
Primary completion
30 Jun 2008
Completion
30 Jun 2008
Last update posted
3 Dec 2015
Registered enrollment
82
Registry id
NCT00257465
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.